Bone Scan Index as a prognostic imaging biomarker during androgen deprivation therapy.
Reza, Mariana LU ; Bjartell, Anders LU ; Ohlsson, Mattias LU
; Kaboteh, Reza
; Wollmer, Per
LU
; Edenbrandt, Lars
LU
and Trägårdh, Elin
LU
(2014)
In EJNMMI Research
4.
- Abstract
- Bone Scan Index (BSI) is a quantitative measurement of tumour burden in the skeleton calculated from bone scan images. When analysed at the time of diagnosis, it has been shown to provide prognostic information on survival in men with metastatic prostate cancer (PCa). In this study, we evaluated the prognostic value of BSI during androgen deprivation therapy (ADT).
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/4816995
- author
- Reza, Mariana
LU
; Bjartell, Anders
LU
; Ohlsson, Mattias
LU
; Kaboteh, Reza
; Wollmer, Per
LU
; Edenbrandt, Lars
LU
and Trägårdh, Elin
LU
- organization
-
- Nuclear medicine, Malmö (research group)
- BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation
- Urological cancer, Malmö (research group)
- Department of Astronomy and Theoretical Physics - Has been reorganised
- Clinical Physiology and Nuclear Medicine, Malmö (research group)
- EpiHealth: Epidemiology for Health
- publishing date
- 2014
- type
- Contribution to journal
- publication status
- published
- subject
- in
- EJNMMI Research
- volume
- 4
- article number
- 58
- publisher
- BioMed Central (BMC)
- external identifiers
-
- pmid:25386390
- wos:000358052000001
- scopus:84930789518
- ISSN
- 2191-219X
- DOI
- 10.1186/s13550-014-0058-y
- language
- English
- LU publication?
- yes
- id
- a9264779-b11b-4159-8e59-6944a24ea136 (old id 4816995)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/25386390?dopt=Abstract
- date added to LUP
- 2016-04-01 14:11:53
- date last changed
- 2024-01-10 00:22:34
@article{a9264779-b11b-4159-8e59-6944a24ea136,
abstract = {{Bone Scan Index (BSI) is a quantitative measurement of tumour burden in the skeleton calculated from bone scan images. When analysed at the time of diagnosis, it has been shown to provide prognostic information on survival in men with metastatic prostate cancer (PCa). In this study, we evaluated the prognostic value of BSI during androgen deprivation therapy (ADT).}},
author = {{Reza, Mariana and Bjartell, Anders and Ohlsson, Mattias and Kaboteh, Reza and Wollmer, Per and Edenbrandt, Lars and Trägårdh, Elin}},
issn = {{2191-219X}},
language = {{eng}},
publisher = {{BioMed Central (BMC)}},
series = {{EJNMMI Research}},
title = {{Bone Scan Index as a prognostic imaging biomarker during androgen deprivation therapy.}},
url = {{https://lup.lub.lu.se/search/files/3836870/5464250}},
doi = {{10.1186/s13550-014-0058-y}},
volume = {{4}},
year = {{2014}},
}